FindTrial
Sign In

Effect of yoga in patients receiving chemotherapy for early stage bladder cancer

Efficacy of yoga on quality of life and Immune response in patients receiving intravesical chemotherapy for non-muscle invasive bladder cancer (nmibc) - a pilot randomized control trial - N/A

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091126
Enrollment
80
Registered
2025-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C679- Malignant neoplasm of bladder, unspecified

Interventions

Intervention1: YOGA ALONG WITH STANDARD MANAGEMENT AS PER PROTOCOL FOR NON MUSCLE INVASIVE BLADDER CANCER: STRUCTURED YOGA PROGRAMME along with Intravesical chemotherapy with 6 induction cycles Total

Sponsors

AIIMS RISHIKESH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Histologically confirmed NMIBC. Receiving Intravesical Induction phase of Gemcitabine Chemotherapy ECOG Performance Status less than 2. Patients must be physically capable of participating in yoga sessions, including the ability to perform basic physical movements and tolerate moderate physical exertion Patients willing to participate in the study by attending more than 80 percent of yoga sessions and comply with study assessments Not practicing any structured yoga for last 6 months

Exclusion criteria

Exclusion criteria: Histopathologically diagnosed Muscle-invasive bladder cancer Previous or concurrent systemic chemotherapy Contraindications to yoga (e.g.severe musculoskeletal conditions, unmanageable comorbidities). Cognitive or psychiatric conditions that limit adherence to the intervention.

Design outcomes

Primary

MeasureTime frame
uality of Life (QoL) Improvement Measurement Tool: EORTC QLQ-NMIBC24 (validated questionnaire for NMIBC patients)Timepoint: at start of study and at end of 6 weeks—

Secondary

MeasureTime frame
To assess the immune response following a structured yoga intervention Evaluate the impact of yoga on LUTS symptoms experienced during the chemotherapy Examine the effects of yoga on psychological, & social well-being in terms of fatigue , stress & sleep quality Explore participant adherence to the yoga intervention & potential predictors of treatment response.Timepoint: at start of study & at end of 6 weeks—

Countries

India

Contacts

Public ContactAnumanchi Dattasai Subramanyam

AIIMS RISHIKESH

drmittal.ankur@gmail.com9639657019

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026